Glucotrack enters Waiver Agreement and issues New Warrants for 406,198 shares at $7.50 exercise price
On October 13, 2026, Glucotrack, Inc. entered into a Waiver Agreement with holders of warrants originally issued under the July 14, 2026 Securities Purchase Agreement, terminating the Equity Issuance Restriction Right under Section 5.10(a) of the Purchase Agreement (effective as to all Holders) and waiving the VRT Adjustment Right under Section 3(e) of the Existing Warrants (effective only as to executing Holders). In consideration, the Company agreed to issue New Warrants to purchase an aggregate of 406,198 sha...
Key takeaways
Waiver Agreement: Glucotrack secured a waiver from warrant holders terminating the Section 5.10(a) Equity Issuance Restriction under the July 14, 2026 Securities Purchase Agreement (effective as to all Holders) and the Section 3(e) VRT Adjustment Right (effective only as to Holders executing the Waiver).
New Warrants issued: 406,198 shares of Common Stock underlying New Warrants, exercisable at $7.50 per share with a five-year term from the issuance date.
Exercisability condition: New Warrants are not exercisable until the Company obtains stockholder approval under Nasdaq Listing Rule 5635; exercise is also subject to a 9.99% beneficial ownership limitation.
Floor price: Exercise price is subject to customary anti-dilution adjustments with a floor equal to 20% of the closing sale price of Common Stock on the New Warrant issuance date.
Registration exemption: The New Warrants and Warrant Shares are being issued under Section 4(a)(2) of the Securities Act.
Strategic impact: Termination of the Equity Issuance Restriction removes a contractual block on issuing Common Stock or Common Stock Equivalents (other than Exempted Securities) for 90 days following effectiveness of the registration statement and stockholder approval, restoring financing flexibility.
Key metrics
Primary source
TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.
Open SEC filingFollow GCTK in real time
Get material earnings, filing, IR, and earnings-call alerts by email.